By combining targeted mutagenesis, computational refinement, and directed evolution, a modestly active, computationally designed DielsAlderase was converted into the most proficient biocatalyst for [4+2] cycloadditions known. The high stereoselectivity and minimal product inhibition of the evolved enzyme enabled preparative scale synthesis of a single product diastereomer. X-ray crystallography of the enzyme-product complex shows that the molecular changes introduced over the course of optimization, including addition of a lid structure, gradually reshaped the pocket for more effective substrate preorganization and transition state stabilization. The good overall agreement between the experimental structure and the original design model with respect to the orientations of both the bound product and the catalytic side chains contrasts with other computationally designed enzymes. Because design accuracy appears to correlate with scaffold rigidity, improved control over backbone conformation will likely be the key to future efforts to design more efficient enzymes for diverse chemical reactions.
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biocatalysis | computational enzyme design | Diels-Alder reaction | laboratory evolution | enzyme mechanism T he Diels-Alder reaction, one of the most powerful transformations in organic chemistry, generates two carbon-carbon bonds and up to four stereogenic centers in a single concerted step. Although putative enzymes for unimolecular [4+2] cycloadditions have been reported (1) (2) (3) (4) , no naturally occurring enzyme is known to catalyze a bimolecular Diels-Alder reaction (5, 6) . The generation of artificial Diels-Alderases has therefore been a longstanding and alluring goal for protein engineers.
The first noteworthy successes toward this end were achieved with catalytic antibody technology. A range of biocatalysts for both normal and inverse electron-demand Diels-Alder reactions has been elicited in response to immunogenic transition-state analogs (7) (8) (9) (10) (11) (12) . Analogous nucleic acid-based catalysts have been isolated from large random libraries with powerful in vitro selection techniques (13) (14) (15) (16) . In a different line of attack, metal ion catalysis has been combined with diverse biomacromolecular scaffolds to promote several cycloaddition reactions (17, 18) . Although such catalysts often exhibit significant regio-and stereoselectivity, their activities generally are orders of magnitude lower than those typical of natural enzymes.
More recently, computational design has proven effective at generating novel catalytic activities in proteins (19, 20) . This approach was used, for example, to create DA_20_00, an enzyme that catalyzes the enantio-and diastereoselective Diels-Alder reaction between 4-carboxybenzyl-trans-1,3-butadiene-1-carbamate (1) and N,N-dimethylacrylamide (2) (21) . The active site of a β-propeller scaffold was altered to bind the diene and dienophile for productive reaction and to stabilize the cycloaddition transition state electronically with appropriately placed hydrogen bond donors and acceptors (Fig. 1) . Judging from its catalytic proficiency, [k cat /(K diene ·K dienophile )]/k uncat , which reflects the enzyme's ability to lower the activation barrier for reaction (22) , the starting design is a poorer catalyst than analogous catalytic antibodies (9, 11) . However, its low initial activity was increased substantially by targeted mutagenesis of active site residues (21) and installation of a lid element through further computational refinement (23) .
Systematic laboratory evolution is a powerful tool for boosting the efficiency of artificial enzymes (24) . Here, we exploited this approach to further augment the activity of the computationally designed Diels-Alderase, applying extensive random mutagenesis and screening to sculpt a more effective active site for the target reaction. The most advanced catalyst, which exhibits the highest catalytic proficiency reported for any natural or artificial Diels-Alderase, was characterized biochemically and structurally. X-ray crystallographic analysis of its complex with a phosphorylated product analog provides direct insight into the origins of catalysis in this system as well as a basis for understanding the structural changes underlying its enhanced efficiency.
Results
Optimization of the Original Computational Design. As previously described, the first steps toward optimization of DA_20_00 involved systematic mutation of all residues predicted to interact with the substrates or the designed catalytic residues (21) . Six
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mutations, when combined, improved catalytic efficiency 100-fold [compare k cat /(K diene ·K dienophile ) for DA_20_00 and DA_20_10, Table 1 ] (21). Toward further enhancement, we carried out eight consecutive rounds of directed evolution, introducing sequence diversity at random positions in the DA_20_10 gene by errorprone PCR (epPCR). The resulting libraries were screened for variants exhibiting improved production and/or catalytic activity.
In each evolutionary round, one to five mutations were introduced per gene, and the activity of 720 variants was assessed in microtiter plates by a direct MS-MS assay (SI Materials and Methods and Fig. S1 ). Typically, 1-5% of the total population had activity equal to or higher than either DA_20_10 or the most active clone from the previous round, and these variants were used as input for the following cycle of mutagenesis and screening. Numerous mutations were found that had no effect on activity, either beneficial or deleterious, and these frequently disappeared in subsequent rounds. At the end of the eighth round of evolution, DA_20_20, the most active DA_20_10 descendant, contained five substitutions at surface sites (R50H, V96I, T197R, E288D, and L309S) and two mutations at positions remote from the active site in the hydrophobic core (D232V and H274L) (yellow spheres in Fig. 2A ; sequence in Fig. S2 ). The evolved DA_20_20 showed a 5.5-fold higher catalytic efficiency than DA_20_10 because of an increase in turnover number (k cat ) and a simultaneous decrease in K M for the dienophile (Table 1) .
In parallel with these laboratory evolution experiments, Eiben et al. (23) submitted DA_20_10 to additional rounds of computational refinement. They hypothesized that the activity of the catalyst was limited by its very open active site and with the help of players of the online game Foldit, designed CE6, a variant of DA_20_10 containing a 24-residue helix-turn-helix motif (shown in cyan in Fig. 2B ) that functions as a lid to constrain the substrates in a productive orientation for reaction (23) . This structural element improved the enzyme's affinity for both substrates, judging from the lower K M values, but left k cat unchanged (Table 1) . Compared with DA_20_20, CE6 exhibits a twofold lower turnover number but a fivefold higher chemical proficiency. Directed evolution and computational redesign thus provided complementary optimization pathways for DA_20_10.
Further Evolutionary Refinement. To generate even better DielsAlderases, we combined all mutations found during the laboratory evolution of DA_20_10 with the lid structure designed in CE6. Despite targeting different regions of the protein, the results of the two optimization strategies were not additive. Because of compensating effects on k cat and K M , the new variant, CE11, has a k cat /(K diene ·K dienophile ) value intermediate between that of its precursors (Table 1) . It was therefore subjected to further directed evolution. As in the earlier optimization rounds, the gene encoding CE11 was diversified by epPCR. All variants that showed improved activity after four rounds of diversification and screening shared two mutations in the engineered helix-turnhelix motif: T43I in direct contact with the substrates and R56S on the solvent-exposed supporting helix. Subsequent random mutagenesis consequently focused exclusively on this structural element. Over four additional rounds of laboratory evolution, mutations were found at most positions in the targeted segment. In the helix designed to interact with the substrates (residues 36-44), conservative substitutions were found at three sites (S39T, E40D, and K44R/N). The solvent-exposed supporting helix and the interhelical loop proved even more tolerant to mutation. Residues 45-56 were all substituted at least once and often by two or three different amino acids. Only four mutations-T43I, P48L, K53E, and R56S-persisted over the entire evolutionary trajectory. The best variant to emerge after eight rounds of mutagenesis and screening, CE20 (Fig. 2B , red and blue spheres), contained these substitutions as well as an additional mutation in the helix that interacts with the substrates (K44N) and two mutations in the supporting helix (S55R and G57D).
Characterization of CE20. CE20 was characterized kinetically by measuring the dependence of reaction velocity on dienophile concentration at several fixed diene concentrations. The pattern of intersecting lines in the double-reciprocal plot (Fig. 3A) indicates that the diene and dienophile bind independently to the enzyme active site (25) . The steady-state kinetic parameters obtained by globally fitting the data to a random binding mechanism are summarized in Table 1 . As a consequence of increases in k cat and decreases in the K M values, this Diels-Alderase is 6 times more efficient than CE6 and 16 times more efficient than DA_20_20 (Table 1) . Overall, CE20 has a 100-fold higher effective molarity (k cat /k uncat ) and a 9,700-fold higher chemical proficiency than the original DA_20_00 computational design ( Table 1) .
As expected for concerted cycloaddition of diene 1 and dienophile 2, the rate of the CE20-catalyzed reaction is pH independent in the range 5-10 ( Fig. 3B) . As per design (21) , the evolved catalyst only promotes stereoselective formation of the 3R,4S endo product; none of the other possible diastereomers could be detected by chiral HPLC analysis of the reaction mixture (Fig. 3C) . Finally, although product inhibition often hampers enzyme-catalyzed bimolecular reactions, this is minimal in the case of CE20. The half-maximal inhibitory concentration (IC 50 = 0.42 mM) of the phosphorylated product analog 4, which has enhanced water solubility compared with 3, is similar in magnitude to the value of K diene , facilitating efficient substrate processing (Fig. S3A) . As a result, CE20 can conduct >770 turnovers at room temperature without signs of inactivation (Fig. S3B ).
The optimized features of CE20 enabled preparative-scale synthesis of the reaction product in aqueous buffer and at room temperature. Greater than 90% conversion was observed, yielding 30 mg of the 3R,4S endo cyclohexene product isomer after isolation (SI Materials and Methods). By comparison, refluxing the substrates in toluene for several days in the absence of catalyst affords a 66:34 mixture of racemic endo and exo products (26) . The artificial DielsAlderase thus provides a mild and practical alternative to standard chemical synthesis, and is notable with respect to its efficiency and stereoselectivity.
Crystal Structure of CE20. The structure of CE20 in complex with the phosphorylated product analog 4 was determined by X-ray crystallography to a resolution of 2.9 Å (Table S1 ). Overall, it is remarkably similar to the original DA_20_00 computational design (21) and the computationally optimized CE6 intermediate (23) . Pairwise comparison of the respective proteins gives Cα atom rms deviations of ∼0.4 Å ( Table S2 ). The β-propeller scaffold used for the design is evidently quite rigid, as neither the appended helix-turn-helix motif nor extensive mutation alters its fold (Fig. S4) . It is particularly noteworthy that the side chains of the catalytic residues Tyr134 and Gln208 adopt virtually identical orientations in all three structures (Fig. 4A) . The observed rotameric preferences of these side chains are consistent with the predictions of the original design model (21) .
The largest differences between the CE20 and CE6 structures are localized in the appended lid element (Fig. 4B ). In CE6, the two helices of the helix-turn-helix motif are resolved and assume a packing angle of 180°, somewhat larger than the 150°predicted by design (23) . In CE20, the helix designed to interact with the substrates (residues 36-44) overlays well with its counterpart in CE6 (Cα rmsd = 0.2 Å; Table S2 ), but the interhelical loop and the second supporting helix are largely disordered. Residues 51-53 in the solvent-exposed helix completely lack electron density, whereas the side chains of the flanking amino acids at positions 45-50 and 54-58 could not be resolved (Table S2) . Crystal contacts in the vicinity of the helix-turn-helix of CE6 and their absence in CE20 may account for the different geometries observed for the second helix. The crystal structure of CE11 supports this hypothesis (Table S2) : the helix-turn-helix motif in one of the proteins in the asymmetric unit engages in crystal contacts, and the supporting helix is well resolved (packing angle ∼130°), whereas such interactions are absent in the second protein chain, and this helix is disordered. The high mobility of the solventexposed helix compared with the active-site helix rationalizes its relative tolerance to mutation.
Visualization of the phosphorylated product analog 4 at the CE20 active site provides direct insight into catalytically relevant interactions as well as a structural basis for rationalizing the evolutionary improvements. The ligand docks snugly in a deep hydrophobic pocket within the protein. Excluding the 2-aminoethylphosphate moiety, which was introduced to increase solubility and points out into solution, 86% of its solventaccessible surface is buried upon complex formation ( Fig. 4C and Fig. S5 ). Ligand recognition is mediated by 88 van der Waals contacts with the peptide backbone, the side chains of many aliphatic and aromatic residues, and a buried water molecule. Roughly a sixth of these interactions are provided by the appended helical element, which functions as a lid and effectively shields the ligand from bulk solvent (Fig. S6 ). The cyclohexene ring of the product sits at the bottom of the active site pocket, largely filling the available space. Although small interfacial cavities are discernable, implying slightly imperfect shape complementarity, the ligand is fixed in place by extensive hydrophobic contacts, on the one hand, and specific hydrogen bonding interactions with the two catalytic residues on the other (Fig. 4D ). This binding mode agrees quite well with the original design model of the product complex (21) (Fig. 4E ). The high stereoselectivity observed for the catalyst suggests that the diene and dienophile substrates must engage in similar interactions with the protein. As programmed, the side chain of Tyr134 is located at the bottom of the binding pocket, effectively positioned to donate a hydrogen bond to the carbonyl group of the dienophile; the importance of this interaction is underscored by mutagenesis studies with CE11 showing that replacement of Tyr134 by any other amino acid causes complete loss of activity under the screening conditions. The buried water molecule, although somewhat distant in the product complex (Fig. 4 C and  D) , may further stabilize the expanded transition state by providing a second hydrogen-bonding interaction to the dienophile carbonyl group. Placement of the Gln208 side chain amide also is consistent with the design model. It is poised to accept a hydrogen bond from the carbamate NH of the diene and simultaneously donate a hydrogen bond to the dienophile. Nevertheless, an unfavorable electronic interaction between the amide oxygen of Gln208 and the ether oxygen of the diene carbamate (Fig. 4 D and E) may explain why substitution of this residue with methionine decreased the activity of the CE11 variant only twofold.
Discussion
Because Diels-Alder reactions proceed through highly ordered transition states, complementarily shaped protein binding sites may function as "entropy traps" to increase reaction rate (27) . Utilization of binding energy to preorganize the substrates for reaction at an active site represents a simple strategy for overcoming large translational and rotational entropic barriers. Further rate enhancements can be achieved by reducing the energy gap between the highest occupied molecular orbital of the diene and the lowest unoccupied molecular orbital of the dienophile through specific hydrogen bonding interactions (28) .
The computational design process that yielded DA_20_00 relied on both strategies to transform a β-propeller scaffold incapable of catalyzing cycloadditions into an artificial Diels-Alderase (21) . Its success reflects both the choice of catalytic groups for stabilizing the transition state, in this case Tyr134 and Gln208, and effective experimental installation of the idealized active site, or "theozyme," in a suitable protein host. The structure of the CE20-product complex attests to the accuracy of the computational modeling of the catalytic residues. The conformations of the Tyr134 and Gln208 side chains, which donate a hydrogen bond to the dienophile and accept a hydrogen bond from the diene, respectively, closely match the design model and changed negligibly over the entire evolutionary trajectory. Because the design algorithms assume an immobile protein backbone, the relative rigidity of the β-propeller fold undoubtedly was conducive to the accurate placement of the theozyme. When more flexible scaffolds have been used for other computationally designed enzymes, significant discrepancies between model and experiment have been observed (29) (30) (31) .
Despite effective positioning of the catalytic groups in the original DA_20_00 design, considerable refinement of the active site was required to achieve respectable levels of activity. Multiple rounds of directed evolution and further computational refinement helped sculpt a more effective binding pocket without substantially altering the core fold. Tolerance to extensive mutation in this case may also be linked to the robustness of the β-propeller scaffold. The largest leaps in activity were The catalytic residues interact with the ligand as designed. The side-chain phenol of Tyr134 donates a hydrogen bond to the carboxamide carbonyl group, whereas the side-chain amide of Gln208 accepts a hydrogen bond from the carbamate NH of the product and donates a hydrogen bond to the carboxamide carbonyl group. The latter interactions are offset by an unfavorable interaction between the Gln208 amide and the carbamate ether oxygen (red dashes). (E) Superposition of the product and catalytic residues shows that the crystal structure (black and yellow carbons) closely matches the original design model (gray and brown carbons). Hydrogen bonds in the design are depicted as black dashes. An unfavorable interaction between Gln208 amide and the carbamate ether oxygen is also evident in the design (3.2 Å in the design vs. 3.0 Å in the crystal structure).
achieved in the early optimization rounds, in which small residues at the bottom of the catalytic pocket were replaced by bulkier amino acids (21) and a lid element was grafted onto the structure to shield the reactants from bulk solvent (23) . These changes, together with the subtle modifications caused by T43I and more distant mutations (Fig. 2) , resulted in gradual contraction of the active site around the highly ordered transition state (Fig. 5 A-C) , enhancing the ability of the Diels-Alderase to constrain the substrates in a reactive orientation with respect to each other and the two catalytic residues. The resulting improvements are manifest in a 10 2 -fold higher "effective molarity" (EM = k cat /k uncat ) for CE20 compared with the original computational design and an ∼10 4 -fold increase in catalytic proficiency (∼1/K TS ). The difference in proficiency reflects the greater affinity of the evolved enzyme for the cycloaddition transition state (22) . Although several mechanistic factors likely contribute to improved molecular recognition of this transient species, the 5.4 kcal/mol of additional stabilization achieved during optimization exceeds the 4.7 kcal/mol predicted by quantum mechanics (21) for electronic stabilization of the transition state by the hydrogen bonding interactions provided by the catalytic residues.
As a consequence of these improvements, CE20 is currently the most proficient Diels-Alderase known. It is 30-to 300-fold more active than catalytic antibodies that promote the same [4+2] cycloaddition (9, 11) , and it outperforms the best artificial enzymes for other Diels-Alder reactions, including antibody catalysts (7-12), ribozymes (13) (14) (15) (16) , and artificial metalloenzymes (17, 18) (Fig. 5D and Table S3 ). For example, antibody 1E9, which accelerates the inverse electron-demand cycloaddition of tetrachlorothiophene dioxide to N-ethylmaleimide (7) and exhibits nearly perfect shape complementarity with its transition-state analog (32) , has a sixfold lower catalytic proficiency. Other artificial Diels-Alderases are one to three orders of magnitude less effective. The catalytic proficiency of CE20 is also 63 times higher than that of SpnF, the only natural Diels-Alderase to be characterized kinetically so far, which promotes a transannular [4+2] cycloaddition in the biosynthesis of the natural product spinosyn A (4).
Compared with other natural enzymes, though, the absolute efficiency of CE20 is modest. It turns over only 10 substrate molecules per hour, and the k cat /K diene and k cat /K dienophile parameters are four to five orders of magnitude lower than the k cat /K M values of moderately efficient natural enzymes (33) . It is possible that additional rounds of directed evolution might improve this DielsAlderase further. Directed evolution of other computational designs, such as the Kemp eliminase HG3 (34) and the retroaldolase RA95 (29) , has afforded 1,000-fold higher chemical proficiencies. Because active site shape complementarity is not yet fully optimal (Figs. 4C and 5) , filling the remaining cavities at the bottom of the pocket might further constrain the substrates and optimize their interactions with the catalytic residues. However, the gains per round of laboratory evolution significantly diminished over the course of evolution, and additional large increases in activity may prove practically elusive. The rigidity of the scaffold may well constrain CE20 evolvability in this instance, precluding the subtle conformational changes of the backbone that might be necessary for attaining perfectly snug transition-state binding. It is also possible that the mechanistic choices implicit in the theozyme intrinsically limit the activities that may be achieved, in which case, different catalytic side chains, or perhaps even metal ion cofactors (35), will be required for more effective substrate activation and transition-state stabilization.
Computational enzyme design has made substantial strides in recent years (19, 20) . Despite impressive accomplishments, though, most structurally characterized designs differ significantly from the original computational prediction, especially with respect to ligand binding and catalytic residue placement (29-31, 34, 36) . The assumption that the protein backbone stays fixed upon installation of a theozyme into a scaffold, made for computational tractability, is a clear weakness of this approach. The good agreement between the original design model of the catalytic site and the experimentally determined structure in the case of the computationally designed Diels-Alderase studied here shows that when the scaffold does not change significantly upon introduction of mutations, the calculations may be quite accurate. This finding suggests that controlling backbone conformation will be a key determinant of future progress in this area. The drawback with rigid scaffolds is that the backbone cannot readily be tuned to the reaction of interest. Properly modeling the reconfigurations of flexible regions of protein scaffolds upon sequence perturbation-and, going further, the custom design of new backbones with geometry optimal for the desired catalytic site-will be important steps toward a next generation of highly active designed catalysts for any desired chemical reaction. 
Materials and Methods
Full details regarding materials and methods are provided in SI Materials and Methods.
In Vitro Evolution. Gene libraries of the most active variants from each round were generated by epPCR using the GeneMorph PCR mutagenesis kit (Stratagene). The Diels-Alder activity of 720 variants per round was assayed in 96-well plates. A solution containing substrates and hexadeuterated product as an internal standard was added to cleared cell lysates and allowed to react for 3.5 h at room temperature before quenching with 50 mM HCl. The reaction mixture was extracted with water-saturated l-butanol, and the product concentration was determined by a direct MS-MS analysis on a Bruker ESI-(Qq)TOF mass spectrometer (maXis) equipped with an Agilent HPLC system (1200). The clones with the largest increase in activity, typically corresponding to about 1% of the screened population, were picked from replica plates for plasmid isolation, sequencing, and further diversification.
Biochemical Characterization. All Diels-Alderase variants were produced as C-terminally His-tagged proteins in Escherichia coli BL21(DE3) and purified by affinity chromatography (Ni-NTA). Catalytic activity was assayed by varying the dienophile concentration at several fixed concentrations of diene at 25°C in PBS buffer containing 4% DMSO and 40 μM hexadeuterated product as an internal standard. Reactions were incubated for 2.5 h at room temperature before acid quenching, extraction, and MS-MS measurement. Steady-state parameters were obtained by fitting the data to the Michaelis-Menten equation. The pH-rate profiles were determined under subsaturating conditions by using acetate buffer for pH 4-6 and Bis-Tris propane for pH 6-10, both containing 100 mM NaCl. Product enantiomers were separated by analytical chiral normal phase HPLC.
Crystallization and Structure Determination. The proteins were crystallized using the hanging and sitting drop diffusion methods, and their structures were solved by molecular replacement. See SI Materials and Methods for detailed procedures and a summary of crystal parameters, data collection, and refinement statistics for the CE11 structure (PDB ID code 4O5S) and the CE20 structure with product analog (PDB ID code 4O5T).
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Preiswerk et al. 10 .1073/pnas.1401073111 SI Materials and Methods Library Construction. The gene encoding DA_20_10 was subcloned into the commercial vector pET-29b(+) (Novagen). All primers were purchased from Microsynth AG. The flanking primers used for library cloning were pET_NdeI (5′-GTT TAA CTT TAA GAA GGA GAT ATA CAT ATG G), and pET_XhoI (5′-TCA GTG GTG GTG GTG GTG GTG CTC GAG G); restriction sites are underlined. Random mutations were introduced over the entire gene encoding DA_20_10 and its descendants by error-prone PCR (epPCR) with the GeneMorph II mutagenesis kit from Agilent Technologies using 10 ng template DNA for errorprone amplification, an amount one order of magnitude smaller than recommended by the manufacturer. The mutational frequencies varied from one to five mutations per 1,000 base pairs. The linear epPCR library fragment and the pET-29b(+) vector containing a stuffer fragment were digested using NdeI and XhoI endonucleases (New England Biolabs), gel purified, and ligated using T4 DNA ligase (New England Biolabs). Following purification with the DNA Clean & Concentrator-5 kit from Zymo Research, the resulting plasmids were used to transform XL1-Blue cells (Agilent Technologies) by electroporation; 1% of the transformed cells were plated on LB agar containing kanamycin. Library quality and mutation rate were assessed by sequence analysis of plasmids from randomly picked single colonies. The remaining 99% were grown as a dense culture overnight in the presence of kanamycin for plasmid amplification and purification. Plasmid libraries were stored at −20°C and used to transform chemically competent BL21(DE3) cells (Agilent Technologies) shortly before screening.
To introduce random mutations over the segment corresponding to the helix-turn-helix lid element (residues 36-60), the GeneMorph II mutagenesis kit was used with the primers fepPCR_for (5′-ACG GCG ATT TTT ATG TGG TG) and fepPCR_rev (5′-GTT TTC AGA TCG ATA TGC AG). To obtain a mutational load of one to three mutations per 300 bases, three epPCR amplifications with 0.1 ng template DNA were run consecutively. The resulting 121-bp-long library was used as a primer together with pET_NdeI to amplify the 5′ fragment of the gene and, in concert with the T7 terminator primer (T7-term: 5′-TGC TAG TTA TTG CTC AGC GG), to amplify the 3′ fragment of the gene. For assembly, 100 ng of each fragment was combined over 30 PCR cycles (denaturation: 10 min at 98°C; annealing: 30 min at 57°C; and elongation: 35 min at 72°C). The flanking primers, pET_NdeI and T7-term, then were added for 10 additional cycles to amplify the full-length gene. The assembled library was inserted into the pET29b(+) vector as described above.
Random mutagenesis of the DNA sequence encoding the helixturn-helix motif was also performed using mutagenic dNTP analogs with the JBS dNTP-Mutagenesis Kit from Jena Bioscience. This technique involves incorporation of the dNTP analogs 8-oxo-dGTP and (6-(2-deoxy-β-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-C][1,2]oxazin-7-one) (dPTP), which induce base mispairing upon DNA amplification. The manufacturer's recommendations were followed. Mutagenic amplification was carried out with the flanking primers T7 (5′-TAA TAC GAC TCA CTA TAG G) and T7-term. The final PCR for elimination of the dNTP analogs was performed with the primers fepPCR_for and fepPCR_rev. The resulting fragments were assembled and inserted in the vector as described above.
Finally, the DNA encoding the helix-turn-helix element was synthesized using spiked nucleotides (1) composed of 96% original nucleotide and 4% other nucleotide as building blocks.
In each codon, the first two positions could be mutated with a 4% probability to any other nucleotide, whereas at the wobble position, only G and T were permitted. Constant regions synthesized with pure nucleotides were appended up-and downstream of the spiked region to ensure good annealing to the template sequence. A reverse primer was designed to be complementary to the 5′ constant region of the spiked primer (5′-CGC CAC CAC TAT AAA ATC) and used in concert with the primer T7 to amplify the 5′ fragment of the full-length gene. The 3′ fragment of the full-length gene was prepared by amplification over 25 96% T, 4% G; 6: 96% G, 4% T], followed by addition of the flanking primer pET_XhoI and another 25 cycles for maximum yield. The resulting fragments were assembled and inserted in the vector as described above.
Screening. In every round of evolution, 720 clones were screened. Single-colony transformants were grown overnight in 100 μL 2YT (16 g tryptone, 10 g yeast extract, and 5 g NaCl dissolved in 1 L water; pH value adjusted to 7.0 by addition of NaOH) containing 50 μg/mL kanamycin in 96-well round-bottom plates at 37°C. A 50-μL fraction of each preculture was used to inoculate 1.2 mL TB medium (12 g tryptone, 24 g yeast extract, and 4 mL glycerol dissolved in 900 mL water; after autoclaving, 100 mL of a solution of 0.17 M KH 2 PO 4 and 0.72 M K 2 HPO 4 was added) containing 50 μg/mL kanamycin, in 2-mL 96-deep-well plates. After 2 h incubation at 37°C (OD 600 ∼ 0.5) protein expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and incubation was continued for 4 h. Cells were harvested by centrifugation, resuspended in 400 μL lysis buffer (20 mM Tris·HCl, pH 8.0; 50 mM NaCl; 1 mM EDTA; 1.5 mg/mL lysozyme), and incubated 15 min at room temperature before storage overnight at −20°C. Lysates were thawed and cell debris was removed by centrifugation; 75 μL supernatant was added to a solution containing substrates and hexadeuterated product (5), which was used as an internal standard, to yield 100-μL solutions containing 100 mM 1, 400 μM 2, and 20 μM 5 in 300-μL round-bottom 96-well plates. The enzymatic reaction was allowed to proceed for 3.5 h at room temperature and then quenched by addition of 50 mM HCl.
Product concentration was determined by a direct MS-MS assay based on a previously described method (2) . Reaction product and deuterated standard were extracted with 120 μL water-saturated l-butanol. The emulsion created by thorough mixing was disrupted by centrifugation, and 20 μL of the organic phase was transferred to a 384-well plate containing 40 μL 1% ammonium acetate in MeOH. Product concentration was analyzed with a Bruker ESI-(Qq)TOF mass spectrometer (maXis) equipped with an Agilent HPLC system (1200). Liquid chromatography conditions were optimized to minimize elution time. The final conditions involved direct injection of 20 μL product solution and isocratic elution with acetonitrile/water [(vol/vol) 90/10] at a flow rate of 0.4 mL/min for 40 s. The multiwell plates were kept at 5°C to avoid solvent evaporation. The samples were analyzed by electrospray ionization (ESI) in negative ion mode by using capillary and endplate voltages of 4,500 V and −500 V, respectively; dry gas (nitrogen 99.99% purity) at 8.4 L/min and 200°C; a nebulizer pressure of 1.6 bar; a TOF flight tube voltage of 9,860 V; a reflection voltage of 1,700 V; a pulser push voltage of 1,610 V; and a TOF detector voltage of 3,450 V. The MS-MS measurements were performed in the multiple-reaction monitoring mode. Precursor ions with m/z = 347.5 ± 6.5 were isolated and fragmented using argon as the collision gas at a 35% flow rate and a fixed collision energy (18 eV; in-source collision-induced dissociation 50 eV). The intensity of the m/z = 211 (obtained from 3) and 217 (obtained from 5) fragment ions was averaged over the entire recording period with the Data Analysis 4.0 software (Bruker Daltonics). The magnitude of the 211/217 ratio provided a robust and sensitive determination of product concentration in the sample. Fig. S1 shows the structure of 5 and an example of the MS-MS spectrum used for product quantification.
Protein Production and Purification. Individual variants were produced as C-terminally His-tagged proteins in Escherichia coli BL21(DE3) and purified by affinity chromatography for biochemical characterization. To ensure monoclonality, single-colony streakouts were used to inoculate overnight cultures in 2× YT medium containing 50 μg/mL kanamycin. Larger volumes of antibiotic-containing TB medium (50-1,000 mL) were inoculated by diluting the precultures 100-fold and incubated at 37°C until an OD 600 of 0.5 was reached. Protein expression was induced by the addition of 0.2 mM IPTG, and incubation was continued for 6 h at 37°C. Cells were harvested by centrifugation, and pellets were stored at −20°C or processed directly for protein purification. Cell pellets were resuspended in 10 mL PBS buffer (10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 137 mM NaCl, and 2.7 mM KCl, pH 7.4) per gram pellet; 2 mg/mL egg white lysozyme (Sigma) was added, and the mixture was incubated for 30 min at room temperature for lysis. If the lysate became very thick, 1 mg DNase I and RNase A were added. Cell debris was removed by centrifugation, and 20 mM imidazole (Acros) was added to the cleared lysate before loading on an Ni-NTA resin column (Qiagen) preequilibrated in 30 mM imidazole-containing PBS. The column was washed with PBS buffer containing 30 mM imidazole before elution with 200 mM imidazole in PBS. Buffer was exchanged to PBS in Amicon Ultra-15 concentrators with a 10-kDa cutoff (Millipore). For crystallization purposes, proteins were purified further by size-exclusion FPLC on a calibrated Superdex 75 HR 10/30 (GE Healthcare) with 25 mM Hepes buffer (pH 7.5) containing 150 mM NaCl. At a flow rate of 0.5 mL/min, the proteins eluted as a single peak at 12 mL, as expected for a 37-kDa protein that does not form higher-order oligomers in solution. Protein concentration was determined with a NanoDrop spectrophotometer using a calculated extinction coefficient at 280 nm of 46,910 M −1 ·cm −1 (http://expasy.org/tools/protparam.html). Protein purity was assessed by SDS/PAGE, and protein identity was confirmed by ESI-MS. Pure protein solutions were stored at 4°C.
Kinetic Analysis. Diels-Alder reactions were run in PBS buffer at 25°C with 4% (vol/vol) DMSO and 40 μM 5. Dienophile concentrations were varied (0, 5, 10, 20, 40, and 150 mM) at fixed concentrations of diene (100, 150, 200, 400, 600, and 900 μM) in the presence or absence of 6 μM CE20. Reactions were incubated for 2.5 h at room temperature before acid quenching, extraction, and MS-MS measurement as described above. The experimental data were corrected for background and globally fitted to the following equation as described by Siegel et al. (3) :
pH-Rate Profiles. The pH dependence of the enzymatic reaction was determined by measuring the rates of substrate conversion at 4.5 μM CE20, 90 μM diene, and 5 mM dienophile in the presence of 10 μM deuterated standard and 4% (vol/vol) DMSO in different buffers. Acetate buffer was used for pH 4-6 and BisTris propane for pH 6-10, both containing 100 mM NaCl. The rate of the uncatalyzed reaction was measured with identical samples lacking the enzyme and subtracted. Product formation was monitored as described above.
Stereoselectivity. Samples containing 2 mM diene, 200 mM dienophile, 80 μM CE20, and 4% (vol/vol) DMSO in 500 μL PBS buffer were incubated at 37°C for 22 h. The reactions were quenched by addition of 50 mM HCl, and product was extracted with 3 × 500 μL ethyl acetate. Solvent was removed by evaporation, and samples were resolubilized in 200 μL PBS buffer. Reverse-phase HPLC (XBridge C18, 3.5 μm, 4.6 × 150 mm at 1 mL/min H 2 O/ACN 5:95-60:40 in 35 min) was used to separate product and unreacted diene and dienophile as previously described (4) . The fractions were lyophilized and resolubilized in 200 μL hexane/isopropyl alcohol (IPA) 69:31. Product enantiomers were separated by analytical chiral normal phase HPLC (Chiralpak AD-H, 5 μm, 4.6-250 mm at 0.5 mL/min hexanes/IPA 69:31; λ = 254 nm) (4).
Reactions were run in the presence of increasing concentrations of the phosphorylated product analog 4 (0, 0.1, 0.3, 0.5, 1, 2, and 3 mM) at 300 μM diene, 100 mM dienophile, 40 μM internal standard, 4% (vol/vol) DMSO, and 3 μM CE20 in PBS at 25°C for 2.5 h. After acid quenching, the samples were extracted and analyzed by tandem MS as described above. Halfmaximum inhibitory concentration (IC 50 ) values were determined by curve fitting (Hill slope model with the rate at infinite inhibitor concentration set to 0).
Turnover Determination. The number of catalytic turnovers before CE20 inactivation was determined by running the enzymatic and nonenzymatic reactions in an Amicon Ultra-5 concentrator with a 10-kDa cutoff (Millipore). The initial concentrations were 2 mM diene, 200 mM dienophile, and 80 μM deuterated standard with or without 6 μM CE20. The samples were incubated at room temperature for 50 h before centrifugation of the reaction mixture to a final volume of 100 μL. A volume of 400 μL of fresh substrate solution was added to the concentrated protein solution and incubated again. This procedure was repeated five times. The product produced at the end of each cycle was determined by MS-MS analysis of the flow-through solutions as described above. The number of total turnovers was calculated by dividing the product concentration in each sample by the initial enzyme concentration.
Crystallization of CE11 and CE20. Crystals of CE11 were obtained at 23°C by using the hanging drop diffusion method by mixing 1 μL of protein solution (11.7 mg/mL) in buffer (25 mM Hepes, pH 7.5, 150 mM NaCl) with 1 μL of reservoir solution containing 24.0% wt/vol polyethylene glycol 3350 and 0.2 M ammonium nitrate. Drops were equilibrated over a reservoir volume of 500 μL, and crystals appeared after 3-5 d. Crystals were soaked for 120 s in cryo buffer containing 10% (vol/vol) PEG 400, 22% (wt/ vol) PEG 3350, and 0.2 M ammonium nitrate and flash frozen in liquid nitrogen. Crystals of CE20 with the phosphorylated product analog 4 were obtained at 20°C using the sitting drop vapor diffusion method by mixing 100 nL CE20 solution (15.5 mg/mL) in buffer (20 mM Hepes, pH 8.0, 150 mM NaCl), containing 20 mM product analog, with 100 nL of reservoir solution containing 20.0% (wt/vol) PEG 3350 and 0.2 M magnesium chloride. Drops were equilibrated over a reservoir volume of 30 μL, and crystals reached final dimensions within 3 d. Crystals were flash frozen in liquid nitrogen.
Crystallographic Methods. Diffraction data were collected at 100 K on the PX-I (for CE20) and PX-III (for DA CE11) beamline at the Swiss Light Source. The diffraction data were processed with XDS (5) and scaled with SADABS (6). The structure of CE11 was solved with Molrep (7) using the scaffold protein PDB ID code 1E1A (8) . The structure of CE20 was solved with PHASER (9) using chain A of CE11. In both structures, two molecules were found per asymmetric unit. Refinement was carried out with Refmac (10) within the CCP4 suite (11) . For CE20, Prosmart (12) was used to generate external restraints based on the structure of CE11, omitting residues of the helix-turn-helix motif. The ligand model and restraints were generated with JLigand (13), and the ligand was fitted into the positive electron density in the active site. The occupancy of the ligand was determined as 70% (chain A) and 50% (chain B). Each model was improved by iterative rounds of refinement and manual rebuilding. The N and C termini are disordered in both structures. Additionally, residues 45-54 in the B chain of CE11, and residues 51-53 (chain A) and residues 53-55 (chain B) in CE20 are disordered. Resolution estimation was performed by using an I/σ(I) criterion of 2 (1.80 Å for CE11 and 3.10 Å for CE20). Additionally, for the CE20 dataset, the split-half correlation CC(1/2) criterion was used to avoid discarding highly important data (14) . Thus, data up to 2.90 Å were used for refinement of CE20. The data statistics and refinement in Table S1 are based on this data cutoff.
Model validation was carried out with the MolProbity server (15) . For CE11, there are 95.4% residues in the most favored regions of the Ramachandran plot and 4.6% in the additionally allowed regions, with no outliers, MolProbity score: 1.31 (this structure is in the 98th percentile for n = 11,444, 1.80 ± 0.25 Å). For CE20, there are 94.8% residues in the most favored regions of the Ramachandran plot and 4.9% in the additionally allowed regions, with only two outliers (0.3%), MolProbity score: 1.78 (this structure is in the 100th percentile for n = 3,760, 2.90 ± 0.25 Å). The programs PyMOL (DeLano Scientific LLC) and CCP4mg (16) were used for figure preparation.
Enzymatic Synthesis of 3. A solution of 4-carboxybenzyl trans-1,3-butadiene-1-carbamate (4) (39 mg, 0.16 mmol) in DMSO was added to 150 mL PBS buffer containing CE20 (3.5 μM) and N,Ndimethylacrylamide (1.5 mL, 100 mM). The reaction mixture was allowed to react at room temperature for 5 d with mild shaking. At the end of the reaction, corresponding to >90% substrate conversion as judged by HPLC, the enzyme was removed by ultrafiltration with Amicon Ultra-15 filter units (10-kDa cutoff), which subsequently were washed three times with water. The protein-free solution was acidified with 6 M HCl (pH 1) and extracted three times with ethyl acetate (200 mL). The solvent was evaporated and the oily residue dissolved in 5 mL 50% acetonitrile in water containing 0.1% TFA. The crude product was purified by preparative HPLC using a C-18 column. Productcontaining fractions were pooled and lyophilized. The 3R,4S endo compound was obtained in 60% yield (30 mg) as an offwhite powder. Error bars effect the SD of three independent measurements. (B) Batch-to-batch catalyst stability was evaluated by allowing CE20 to react with substrate at high concentration (2 mM diene and 200 mM dienophile) for 50 h at room temperature in PBS buffer. The amount of product formed was determined by the standard MS-MS assay. After the catalyst was separated from the small molecules by ultrafiltration, a fresh batch of substrate was added and the process repeated. As shown, CE20 remains fully active for 10 d at 25°C. Over five cycles, a total of 770 turnovers were achieved. Fig. S4 . Overlay of the DA_20_00, CE6, and CE20 structures. With the exception of the engineered lid segment (top), the CE20 scaffold (orange, PDB ID code 4O5T) is very similar to that of DA_20_00 (black, PDB ID code 3I1C) and CE6 (gray, PDB ID code 3U0S). Fig. S5 . Omit map of the ligand binding site in CE20 chain A. The phosphorylated product analog 4 is shown with carbon, oxygen, nitrogen, and phosphorus atoms in black, red, blue, and orange, respectively. The engineered helix-turn-helix motif (residues 36-58) is depicted in green. Electron density is contoured at 1.0σ and was calculated without the ligand or the side chains of Tyr134 and Gln208. Fig. S6 . Interaction of the engineered helix-turn-helix motif with the product in the crystal structure of CE20. Three residues in the lid element-Ser39, Leu42, and Ile43-engage in van der Waals contacts with the phosphorylated product. Ser39 and Leu42 were present in the computationally designed CE6 variant, whereas residue Ile43 was introduced during evolutionary optimization by mutation of a threonine originally at this position. Both threonine and isoleucine are beta-branched amino acids, but the mutation to isoleucine introduces an additional methyl group that can interact productively with the dimethylamide substituent of the ligand (dashed lines), improving overall shape complementarity. This new contact probably helps position the dienophile during catalysis. 
